Risk of Events by Age and Treatment in ENGAGE AF-TIMI 48
ENAGE AF-TIMI 48, Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation; HDE, high-dose edoxaban; ICH, intracranial hemorrhage; LDE, low-dose edoxaban; SEE, systemic embolic event; W, warfarin.Reproduced with permission from ET Kato, MD, PhD.